NCT07348211 2026-01-23SIM0610-101Jiangsu Simcere Pharmaceutical Co., Ltd.Phase 1 Recruiting260 enrolled
NCT06948539 2025-04-29To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant TumorsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1 Not yet recruiting66 enrolled
NCT03511963 2024-12-31A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRCShanghai Henlius BiotechPhase 3 Completed677 enrolled
NCT00041808 2005-06-24Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverFeRxPhase 1/2 Completed20 enrolled